Immuneering (IMRX) Retained Earnings: 2020-2023
Historic Retained Earnings for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$163.3 million.
- Immuneering's Retained Earnings fell 39.19% to -$206.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$206.2 million, marking a year-over-year decrease of 39.19%. This contributed to the annual value of -$163.3 million for FY2023, which is 48.70% down from last year.
- As of FY2023, Immuneering's Retained Earnings stood at -$163.3 million, which was down 48.70% from -$109.8 million recorded in FY2022.
- In the past 5 years, Immuneering's Retained Earnings ranged from a high of -$25.7 million in FY2020 and a low of -$163.3 million during FY2023.
- In the last 3 years, Immuneering's Retained Earnings had a median value of -$109.8 million in 2022 and averaged -$110.8 million.
- Data for Immuneering's Retained Earnings shows a maximum YoY plummeted of 130.30% (in 2021) over the last 5 years.
- Immuneering's Retained Earnings (Yearly) stood at -$25.7 million in 2020, then crashed by 130.30% to -$59.3 million in 2021, then crashed by 85.22% to -$109.8 million in 2022, then tumbled by 48.70% to -$163.3 million in 2023.